Clinical Trial Update: Mycophenolate Mofetil for IgA Nephropathy [Phase 4]

View source ↗

Summary

Phase 4 trial update indicating that the study evaluating mycophenolate mofetil for IgA nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: The University of Hong Kong | Conditions: IGA Nephropathy | Phase 4 | Status: COMPLETED